ULTRALIFE CORP (ULBI) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the 2026 Annual Meeting of Stockholders held on July 22, 2026. The filing date is July 23, 2026. As of the record date (May 28, 2026), there were 16,656,669 shares of common stock outstanding. A quorum was established with 13,980,794 shares (83.93%) present in person or by proxy.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes.
Material Changes and Voting Results
The following proposals were voted upon by stockholders:
- Election of Directors: All five nominees were elected to serve one-year terms. Broker non-votes totaled 2,700,325 shares for each director.
- Ratification of Auditors: Stockholders ratified WithumSmith+Brown, PC as the independent registered public accounting firm for 2026.
- Executive Compensation (Say-on-Pay): Stockholders approved the advisory resolution on executive compensation.
- Frequency of Say-on-Pay Votes: Stockholders indicated a preference for future advisory votes on executive compensation to occur every 3 years. The Board of Directors has determined to adopt this 3-year frequency.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the final composition of the Board of Directors following the election of Michael E. Manna, Janie Goddard, Thomas L. Saeli, Robert W. Shaw II, and Bradford T. Whitmore.
- Confirm the implementation of the 3-year frequency for future executive compensation advisory votes as determined by the Board.
- Review the full proxy statement for details on the specific executive compensation plan approved by stockholders.
- Note that approximately 2.7 million shares were broker non-votes, which may impact future voting thresholds.